Arcus Biosciences to Participate in the Jefferies Global Healthcare Conference 2026 in London
Business Wire•02/11/2026•16:05 ET
0
Key Highlights
- ➤Management to participate in Jefferies Global Healthcare Conference fireside chat
- ➤Fireside chat scheduled for November 16, 2026, at 5:00pm GMT
- ➤Casdatifan and quemliclustat advanced to Phase 3 oncology trials
Arcus Biosciences to Participate in the Jefferies Global Healthcare Conference 2026 in London
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and immune diseases, announced that its management team will participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference in London, UK. The fireside chat will take place on Monday, November 16(th), 2026, at 5:00pm GMT.
Get started
Create a free account to read the full story.